Tobacco giant Philip Morris strikes €1.1bn deal for inhaler firm Vectura
Tobacco giant Philip Morris International (PMI) has agreed to buy British inhaler maker Vectura for £1bn (€1.16bn), as it expands into healthcare which treats conditions its cigarettes can help cause.
The Marlboro owner is offering 150p per share for the London-listed target, the companies said on Friday.




